Brian Nagle - 16 Oct 2025 Form 4 Insider Report for MARCHEX INC (MCHX)

Reporting relationship: Chief Financial Officer
Issuer ticker: MCHX
Reported as of: 16 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Oct 2025, 16:15:06 UTC
Prior SEC filing: 21 Mar 2025
Next SEC filing: 18 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian Nagle

Key filing fact

Brian Nagle filed Form 4 for MARCHEX INC (MCHX) on 17 Oct 2025.

Key facts

This page summarizes Brian Nagle's Form 4 filing for MARCHEX INC (MCHX).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 17 Oct 2025, 16:15.

Change

Previous filing in this sequence was filed on 21 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002059841 Primary reporting owner

Nagle Brian

Relationship: Chief Financial Officer
Address: 1200 5TH AVE, SUITE 1300, SEATTLE
Signature: /s/ Brian Nagle
Signature date: 17 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MCHX transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +125,000
Change %
Price: $0.000000
Shares after: 125,000
Date: 16 Oct 2025
Ownership: Direct
Underlying class: Class B Common Stock
Underlying amount: 125,000
Exercise price
Footnotes: F1

MCHX transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +125,000
Change %
Price: $0.000000
Shares after: 125,000
Date: 16 Oct 2025
Ownership: Direct
Underlying class: Class B Common Stock
Underlying amount: 125,000
Exercise price: $1.81
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units award effective October 16, 2025 (the "Grant Date"). Each restricted stock unit represents the right to receive one share of the Corporation's Class B Common Stock upon vesting, which occurs in full on the fourth anniversary of the Grant Date.

Footnote F2

Stock options award effective October 16, 2025 (the "Grant Date"), with vesting over four years, 25% of the total option shares vesting on the first anniversary of the Grant Date and the remainder vesting quarterly thereafter over the next three (3) year period in equal increments of 6.25% of the aggregate amount of such shares, subject to acceleration of vesting in certain events.